Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 3
2020 1
2021 5
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation.
Chirumbolo G, Dicataldo M, Barone M, Storci G, De Matteis S, Laprovitera N, Sinigaglia B, Barbato F, Maffini E, Cavo M, Bonifazi F, Arpinati M. Chirumbolo G, et al. Among authors: laprovitera n. Transplant Cell Ther. 2023 May;29(5):302.e1-302.e8. doi: 10.1016/j.jtct.2023.02.008. Epub 2023 Feb 14. Transplant Cell Ther. 2023. PMID: 36796518
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity.
De Matteis S, Dicataldo M, Casadei B, Storci G, Laprovitera N, Arpinati M, Maffini E, Cortelli P, Guarino M, Vaglio F, Naddeo M, Sinigaglia B, Zazzeroni L, Guadagnuolo S, Tomassini E, Bertuccio SN, Messelodi D, Ferracin M, Bonafè M, Zinzani PL, Bonifazi F. De Matteis S, et al. Among authors: laprovitera n. Front Immunol. 2023 Jan 16;13:1058126. doi: 10.3389/fimmu.2022.1058126. eCollection 2022. Front Immunol. 2023. PMID: 36726971 Free PMC article.
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients.
Storci G, Barbato F, Ricci F, Tazzari PL, De Matteis S, Tomassini E, Dicataldo M, Laprovitera N, Arpinati M, Ursi M, Maffini E, Campanini E, Dan E, Manfroi S, Santi S, Ferracin M, Bonafe M, Bonifazi F. Storci G, et al. Among authors: laprovitera n. Front Immunol. 2023 Jan 13;13:1058739. doi: 10.3389/fimmu.2022.1058739. eCollection 2022. Front Immunol. 2023. PMID: 36713433 Free PMC article.
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer.
Miglietta S, Girolimetti G, Marchio L, Sollazzo M, Laprovitera N, Coluccelli S, De Biase D, De Leo A, Santini D, Kurelac I, Iommarini L, Ghelli A, Campana D, Ferracin M, Perrone AM, Gasparre G, Porcelli AM. Miglietta S, et al. Among authors: laprovitera n. Noncoding RNA. 2022 Sep 25;8(5):64. doi: 10.3390/ncrna8050064. Noncoding RNA. 2022. PMID: 36287116 Free PMC article.
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy.
De Matteis S, Casadei B, Lolli G, Dicataldo M, Barbato F, Dan E, Paccagnella A, Sinigaglia B, Bertuzzi C, Arcari A, Zazzeroni L, Bernuzzi P, Laprovitera N, Storci G, Bertuccio SN, Ferracin M, Bonafè M, Zinzani PL, Bonifazi F. De Matteis S, et al. Among authors: laprovitera n. Front Immunol. 2022 Oct 6;13:994731. doi: 10.3389/fimmu.2022.994731. eCollection 2022. Front Immunol. 2022. PMID: 36275688 Free PMC article.
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer.
Mazzeschi M, Sgarzi M, Romaniello D, Gelfo V, Cavallo C, Ambrosi F, Morselli A, Miano C, Laprovitera N, Girone C, Ferracin M, Santi S, Rihawi K, Ardizzoni A, Fiorentino M, D'Uva G, Győrffy B, Palmer R, Lauriola M. Mazzeschi M, et al. Among authors: laprovitera n. J Exp Clin Cancer Res. 2022 Mar 29;41(1):113. doi: 10.1186/s13046-022-02309-1. J Exp Clin Cancer Res. 2022. PMID: 35351152 Free PMC article.
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report.
Donati G, Abenavoli C, Vischini G, Cenacchi G, Costa R, Pasquinelli G, Ferracin M, Laprovitera N, Comai G, Monti G, Giostra F, La Manna G. Donati G, et al. Among authors: laprovitera n. Am J Case Rep. 2022 Feb 23;23:e934220. doi: 10.12659/AJCR.934220. Am J Case Rep. 2022. PMID: 35194011 Free PMC article.
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson-Fabry disease.
Salamon I, Biagini E, Kunderfranco P, Roncarati R, Ferracin M, Taglieri N, Nardi E, Laprovitera N, Tomasi L, Santostefano M, Ditaranto R, Vitale G, Cavarretta E, Pisani A, Riccio E, Aiello V, Capelli I, La Manna G, Galiè N, Spinelli L, Condorelli G. Salamon I, et al. Among authors: laprovitera n. Cell Death Dis. 2021 Dec 11;12(12):1150. doi: 10.1038/s41419-021-04438-5. Cell Death Dis. 2021. PMID: 34897278 Free PMC article.
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches.
Laprovitera N, Salamon I, Gelsomino F, Porcellini E, Riefolo M, Garonzi M, Tononi P, Valente S, Sabbioni S, Fontana F, Manaresi N, D'Errico A, Pantaleo MA, Ardizzoni A, Ferracin M. Laprovitera N, et al. Front Cell Dev Biol. 2021 Jun 10;9:666156. doi: 10.3389/fcell.2021.666156. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34178989 Free PMC article.
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Laprovitera N, Riefolo M, Porcellini E, Durante G, Garajova I, Vasuri F, Aigelsreiter A, Dandachi N, Benvenuto G, Agostinis F, Sabbioni S, Berindan Neagoe I, Romualdi C, Ardizzoni A, Trerè D, Pichler M, D'Errico A, Ferracin M. Laprovitera N, et al. Mol Oncol. 2021 Oct;15(10):2732-2751. doi: 10.1002/1878-0261.13026. Epub 2021 Jun 23. Mol Oncol. 2021. PMID: 34075699 Free PMC article.
17 results